– Initial results showed that single ascending oral dosing of KUR-101 produces dose-dependent analgesia (pain relief) with effects on respiration comparable to that of placebo. – Topline results, including Part 2 comparing a single dose of KUR-101 to a single dose of oxycodone or placebo, are expected by the end of 2022. – KUR-101 is an oral formulation of deuterated mitragynine…

Source

Previous articleFILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE
Next articlePT364 – Jamie Wheal – Burning Man, Psychedelic Maturity, and Radical Hope